Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial
暂无分享，去创建一个
J. Burger | E. van Meerten | S. Nienhuijs | V. C. van de Vlasakker | I. V. van Hellemond | J. Nederend | A. Brandt-Kerkhof | R. Lurvink | S. Koolen | Niels A. D. Guchelaar | I. D. de Hingh | Ramon Bax | E. Madsen | G. Creemers | C. Verhoef | R. Mathijssen | O. Kranenburg | Teun B M van den Heuvel